Welcome to CDC stacks | GRADE evidence for inactivated Vero cell culture-derived JE vaccine (JE-VC; Ixiaro) in children - 76408 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
GRADE evidence for inactivated Vero cell culture-derived JE vaccine (JE-VC; Ixiaro) in children
Filetype[PDF-4.34 MB]


  • Supporting Files:
    No Additional Files
    1. Pediatric data for IXIARO® Japanese encephalitis vaccine, inactivated, adsorbed
      Personal Author:
      Dubischar-Kastner, Katrin
      Corporate Author:
      Valneva
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2013 June 19-20 : Atlanta, GA)
      Published:
      June 19, 2013
      Series:
      ACIP meeting Japanese Encephalitis Vaccine
      Description:
      02-JE-Dubischar-Kastner.pdf
      File Type:
      Filetype[PDF - 924.00 KB]
    2. Japanese encephalitis (JE) vaccine
      Personal Author:
      Bocchini, Joseph A.
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. Japanese Encephalitis Vaccine Workgroup.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2013 June 19-20 : Atlanta, GA)
      Published:
      June 19, 2013
      Series:
      ACIP meeting Japanese Encephalitis Vaccine
      Description:
      01-JE-Bocchini.pdf
      File Type:
      Filetype[PDF - 1.02 MB]
You May Also Like:
  1. Use of Japanese encephalitis vaccine in children : recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc; Hills, Susan L.; Staples, J. Erin;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases..
    Published:
    November 15, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 45, p. 898-900
    Description:
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include c...
    Status:
    current
    File Type:
    Filetype[PDF - 201.04 KB]
  2. Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc; Hills, Susan L.; Staples, J. Erin;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Nov 15 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(45):898-900.
    Description:
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include c...
    File Type:
    Filetype[PDF - 127.62 KB]
  3. Japanese encephalitis vaccine : recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Hills, Susan L.; Walter, Emmanuel B.; Atmar, Robert L.; Fischer, Marc;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases..
    Conference Author:
    Journal article
    Published:
    July 19, 2019
    Source:
    MMWR. Morbidity and mortality weekly report
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 68, no. 2
    Description:
    This report updates the 2010 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding prevention of Japanese encephalitis (JE) among U.S. travelers and laboratory workers (Fischer M, Lindsey N, Staples JE, Hills S. J...
    File Type:
    Filetype[PDF - 950.12 KB]
  4. Japanese Encephalitis (JE) vaccine = GRADE for inactivated Vero cell culture- derived JE vaccine (JE-VC)
    Personal Author:
    Walter, Emmanuel B.; Hills, Susan L.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices. ACIP Flavivirus Vaccines Workgroup.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch..
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 June 20-21 : Atlanta, GA)
    Published:
    8/14/18
    Series:
    ACIP meeting Japanese Encephalitis Vaccine
    Description:
    Presentations June 2018 Day 2 : Publication date from document properties.
    File Type:
    Filetype[PDF - 1.75 MB]
  5. Japanese encephalitis vaccines; recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Fischer, Marc; Hills, Susan; Lindsey, Nicole; Staples, J. Erin;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Emerging and Zoonotic Infectious Diseases (proposed), Division of Vector-Borne Infectious Diseases.. National Center for Zoonotic, Vector-Borne, and Enteric Diseases (U.S.), Division of Vector-Borne Infectious Diseases., Arbovirus Diseases Branch..
    Published:
    March 12, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-1
    Description:
    "This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations o...
    Status:
    current
    File Type:
    Filetype[PDF - 1.55 MB]